(Q49045963)

18 February 2018

title

Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant. (English)

1 reference

18 February 2018

1 reference

3

Pierre Van Damme

1 reference

18 February 2018

Isabelle Desombere

1

1 reference

18 February 2018

Marie Van der Wielen

2

1 reference

18 February 2018

Michel Stoffel

4

1 reference

18 February 2018

Norbert De Clercq

5

1 reference

18 February 2018

Christian Goilav

6

1 reference

18 February 2018

Geert Leroux-Roels

7

1 reference

18 February 2018

language of work or name

English

0 references

publication date

1 June 2002

1 reference

18 February 2018

published in

Vaccine

1 reference

18 February 2018

volume

20

1 reference

18 February 2018

issue

19-20

1 reference

18 February 2018

page(s)

2597-2602

1 reference

18 February 2018

Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

Over a decade of experience with a yeast recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

Response to hepatitis B vaccine: multiple HLA genes are involved

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

A hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

A prophylactic hepatitis B vaccine with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

Frequency and associations of HLA-DR and HLA-DQ antigens in a British Caucasoid panel

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

HLA class I (A, B) and II (DR, DQ) gene and haplotype frequencies in blood donors from Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900150-0

7 January 2021

10.1016/S0264-410X(02)00150-0

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018